oraCle – 2nd project meeting

The oraCle project is proceeding well. The project partners met in the second meeting, held on 19 June 2017 at the Biofarma SpA headquarters. The meeting, focused on the scientific side of oraCle, saw a useful confrontation on the technical aspects and the definition of the planned activities for the coming months. On the agenda: Any

Transactiva to be partner of MossTech (Marie Curie EID)

MossTech: Advanced use of mosses for biotechnological solutions” is a project based on the Horizon 2020 call “H2020-MSCA-ITN-2017”, or “Marie Sklodowska-Curie Innovative Training Networks”, which provides for the training of 6 young researchers (Early Stage Researchers, ESRs) through industrial doctorate projects at European level (EID, European Industrial Doctorates). Each project involves the participation of a

The “oraCle” project ranks first – approved for funding

In July 2017 Transactiva directed, as leader, a public-private partnership for the participation in the POR FESR 2014-2020 calls, (Activity 1.3.b) – for “R&D projects to be achieved through public-private partnerships – areas of specialization Maritime Technologies and Smart Health”. The project “A new integrated approach for oral therapy of Crohn’s disease: oraCle” was presented

Transactiva @ BioHighTech Companies Day 2016

Second edition of the BioHighTech Companies Day, the day within the TriesteNext manifestation dedicated to innovative companies. Held September 23, 2016 at the Palazzo della Regione, this event presented projects in the BioHighTech field who hatched from public-private partnerships. Organized by Aries [Special Agency of the Trieste Chamber of Commerce], BioHighTech NET, CBM [Centre for Molecular